News & Insights
Xeomics has become an Organizational Member of the Global Alliance for Genomics & Health (GA4GH). a milestone that marks a significant step forward in our mission to advance responsible genomics and global health data innovation.
Xeomics joins the Global Alliance for Genomics & Health as an Organizational Member
NEWS
February 4 2026
By Dr George Zarkadakis, CIO
In the past decade, gene therapies have moved from science fiction to clinical reality. For patients, the results are life-changing. Yet the cost is staggering.
Gene therapies: why lowering costs depends on AI and data diversity
INSIGHTS
October 9 2025
Amplifier Health, a pioneer in revolutionizing healthcare diagnostics through advanced voice-based acoustic models, today announced a strategic partnership with Xeomics, a global leader in precision medicine.
Amplifier Health partners with Xeomics to scale groundbreaking voice biomarker technology
NEWS
October 9 2025
Imagine a world where your doctor prescribes medication tailored specifically to your DNA. That’s the promise of pharmacogenomics, a revolutionary field that brings us closer to truly personalized medicine.
Unlocking personalized medicine through pharmacogenomics
INSIGHTS
October 9 2025
Modern drug discovery and trials too often rely on data drawn from predominantly white populations. That limits how well conclusions generalize to the majority of humanity.
Diverse global clinical datasets are critical for the future of drug research
INSIGHTS
October 9 2025
News & Insights Archive
Xeomics has become an Organizational Member of GA4GH
NEWS | February 4 2026
Gene therapies: why lowering costs depends on AI and data diversity
INSIGHTS | October 9 2025
Amplifier Health partners with Xeomics to scale groundbreaking voice biomarker technology
NEWS | October 9 2025
INSIGHTS | October 9 2025
Diverse global clinical datasets are essential for real progress in drug research